Double trouble: Drug-eluting stenting in a patient of atrial fibrillation
Stroke prevention is important in patients with atrial fibrillation. Dual antiplatelets are important after a drug coated stent implant in patients with coronary artery disease, while patients with atrial fibrillation need anticoagulation. When to give triple therapy with combination dual antiplatel...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Journal of the Practice of Cardiovascular Sciences |
Subjects: | |
Online Access: | http://www.j-pcs.org/article.asp?issn=2395-5414;year=2015;volume=1;issue=2;spage=198;epage=199;aulast=Kumar |
Summary: | Stroke prevention is important in patients with atrial fibrillation. Dual antiplatelets are important after a drug coated stent implant in patients with coronary artery disease, while patients with atrial fibrillation need anticoagulation. When to give triple therapy with combination dual antiplatelets and anticoagulation and how to balance the risk and benefits is discussed in this article. |
---|---|
ISSN: | 2395-5414 2454-2830 |